Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2008
08/20/2008CN101247722A Biphenyl-N- (4-pyridyl) methylsulfonamides
08/20/2008CN100412061C 6-(1,1-difluoroalkyl)-4-aminopicolinates and their use as herbicides
08/19/2008US7414136 Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt
08/19/2008US7414132 prophylaxis and treatment of obesity; secondary amines such as 6-{4-[(3-Methyl-butylamino)-methyl]-phenoxy}-nicotinimidic acid ethyl ester
08/19/2008US7414064 Pesticides for crops; agriculture, horticulture
08/19/2008US7414055 Inhibitors of Akt activity
08/19/2008US7414046 Gyrase inhibitors and uses thereof
08/19/2008CA2488422C Stable solid medicinal ramosetron composition for oral administration
08/14/2008WO2008097235A1 Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines
08/14/2008WO2008097234A1 Process for the preparation of 2-substituted-5-(1-alkylthio) alkylpyridines
08/14/2008WO2008096739A1 Benzimidazole compound-containing composition and light-emitting device using the composition
08/14/2008WO2008095689A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
08/14/2008WO2008073350A3 Acetylene derivatives and their use for binding and imaging amyloid plaques
08/14/2008WO2008065490A3 Process for the preparation of atazanavir
08/14/2008WO2008046838A8 N- (3-pyridin-2-ylpropyl) benzamide derivatives as fungicides
08/14/2008US20080194651 Nitroderivatives as drugs for diseases having an inflammatory basis
08/14/2008US20080194647 Pyridyl Derivatives and Their Use as Mglu5 Antagonists
08/14/2008US20080194645 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
08/14/2008US20080194627 Aryl substituted pyridines and the use thereof
08/14/2008US20080194608 Atherosclerosis therapy; antidiabetic agents; dyslipidemia
08/14/2008US20080194597 Platelet adp receptor inhibitors
08/14/2008US20080194584 Nitrogen Heteroaromatic Compounds Which Bind To The Active Site Of Protein Kinase Enzymes
08/14/2008US20080194583 Tubulin Inhibitors
08/14/2008US20080194551 Acetylene Derivatives
08/14/2008US20080194536 Cyanoarylamines
08/14/2008US20080194521 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
08/14/2008US20080193423 Small organic molecule regulators of cell proliferation
08/14/2008US20080193381 Heterodimers of glutamic acid
08/14/2008CA2677437A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
08/14/2008CA2676700A1 Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines
08/14/2008CA2676072A1 Process for the preparation of 2-substituted 5-(1-alkylthio) alkylpyridines
08/13/2008EP1955996A1 7, 9-Substituted tetracycline compounds
08/13/2008EP1954696A2 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
08/13/2008EP1954678A1 Novel nk1 and nk2 antagonists
08/13/2008EP1954674A1 New n-phenethylcarboxamide derivatives
08/13/2008EP1954271A2 Process for preparing pyridinamines and novel polymorphs thereof
08/13/2008EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
08/13/2008EP1368305B1 7, 9-substituted tetracycline compounds
08/13/2008EP1322309B1 High affinity small molecule c5a receptor modulators
08/13/2008EP0934924B1 Novel diamide compounds and drugs containing the same
08/13/2008CN101243099A Metal complex
08/13/2008CN101243069A Thrombin inhibiting 2-oxo-1,2,5,6-tetrahydropyridine derivatives
08/13/2008CN101243067A Novel anthranilamides for controlling invertebrate pests
08/13/2008CN101243047A Phenoxy acetic acids as PPAR delta activators
08/13/2008CN101242858A Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
08/13/2008CN101240168A Blue light organic luminescent material and preparation method thereof
08/13/2008CN101239944A Method for preparing 2-mercapto-3-trifluoromethylpyridine
08/13/2008CN101239311A Method for converting cyanopyridine compounds into niacinamide compounds, its catalyst and the catalyst preparation
08/13/2008CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
08/13/2008CN100409844C Noval compound, its synthetizing process and therapeutic use
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411061 Method of synthesizing polynucleotides using ionic liquids
08/12/2008US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor
08/12/2008US7410985 Useful for the chelation of ferric (III) ions for the removal of iron in chemical and biological systems; thalassaemia, sickle cell disease haemochromatosis; 1-Cyclopropyl-3-hydroxy-6-methyl-N-(3-methylbutyl)4-oxo-1,4-dihydropyridine-2-carboxamide
08/12/2008US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis
08/12/2008US7410979 Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
08/12/2008US7410971 1,2-di(cyclic)substituted benzene compounds
08/12/2008US7410656 Isolated euphorbia plant compounds and derivatives; jatrophanes, pepluanes, paralianes, ingenanes; cytotoxicity against malignant melanomas and squamous cell carcinomas
08/12/2008CA2188228C Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
08/07/2008WO2008095064A2 High stability diionic liquid salts
08/07/2008WO2008094992A2 2-aminopyridine derivatives useful as kinase inhibitors
08/07/2008WO2008093742A1 Process for production of binuclear metal complex
08/07/2008WO2008093711A1 Solid-phase oxidation reaction system
08/07/2008WO2008093392A1 Process for production of 2,3’-bipyridyl-6’-one
08/07/2008WO2008093236A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
08/07/2008WO2008093065A1 L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS
08/07/2008WO2008093064A1 L-ALANINE DERIVATIVES AS α5 BETA 1 ANTAGONISTS
08/07/2008WO2008077064A3 Biomarker identifying the reactivation of stat3 after src inhibition
08/07/2008WO2008074413A3 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase
08/07/2008WO2008072079A3 Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide
08/07/2008WO2008030266A3 Insecticidal n-substituted (heteroaryl)alkyl sulfilmines
08/07/2008US20080188654 Compounds for treatment of inflammation, diabetes and related disorders
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/07/2008US20080188528 Modulators of C3a receptor and methods of use thereof
08/07/2008US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist;
08/07/2008US20080188489 Cell differentiation inducer
08/07/2008US20080188443 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; modulators of the glucocorticoid receptor; asthma, dermatitis, inflammatory bowel disease, Alzheimer's disease, psychotic major depression
08/07/2008CA2677096A1 Kinase inhibitors
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/06/2008EP1951702A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders
08/06/2008EP1951701A2 Ep2 receptor agonists
08/06/2008EP1951673A2 Heterocyclic cetp inhibitors
08/06/2008EP1951672A1 Potassium channel inhibitors
08/06/2008EP1951663A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
08/06/2008EP1951659A2 Glucagon receptor antagonists, preparation and therapeutic uses
08/06/2008EP1951656A1 Histone deacetylase inhibitors as therapeutics for neurological diseases
08/06/2008EP1951381A1 Novel lipophobic perfluoroalkyl polyamides, preparation thereof and use thereof
08/06/2008EP1951230A2 Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
08/06/2008EP1715938A4 Advanced contaminant treatment system
08/06/2008EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
08/06/2008EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008EP1236712B1 Amidinophenylpyruvic acid derivative
08/06/2008EP1120391B1 Molecular compounds containing novel carboxylic acid derivatives as the constituent compound
08/06/2008CN101237773A Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides
08/06/2008CN101235512A Electrolytic synthesis method for 3,6-dichloropicolinic acid
08/06/2008CN101235054A Multi-pyridinamine nickel four-core metal string material and preparation method thereof
08/06/2008CN101235015A Multi-pyridinamine nickel four-core metal string material without axial direction ligand and preparation method thereof
08/06/2008CN101235014A Method for treating and reclaiming waste water of 2-aminopyridine production
08/06/2008CN101235013A Crystallized 1-(3-fluorophenyl)-5-methyl-2-(1H)pyridine and its preparation method composition and application